{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:54:30Z","timestamp":1777420470980,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.genhosppsych.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:09:27Z","timestamp":1559300967000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions"],"prefix":"10.1016","volume":"59","author":[{"given":"Berker","family":"Duman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaz\u0131m Cihan","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"A\u011fta\u015f-Ertan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyda","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u0131fat Serav","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Kumbasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ula\u015f Mehmet","family":"\u00c7amsar\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0010","series-title":"Valproate-induced hyperammonemic encephalopathy in general hospital patients with one or more psychiatric disorders","first-page":"415","volume":"58","author":"Lewis","year":"2017"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11064-016-2014-x","article-title":"Neurotoxicity of ammonia","volume":"42","author":"Oja","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0020","series-title":"Hyperammonemia in review: pathophysiology, diagnosis, and treatment","first-page":"207","volume":"27","author":"Auron","year":"2012"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0025","series-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","first-page":"93","author":"Tseng","year":"2014"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0030","series-title":"The real mechanism of VPA-induced hyperammonemia remains unknown","volume":"33","author":"Hung","year":"2011"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0035","series-title":"Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management","first-page":"290","volume":"34","author":"Chopra","year":"2012"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0040","series-title":"Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients","first-page":"202","volume":"101","author":"Yamamoto","year":"2012"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0045","series-title":"The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?","first-page":"361","volume":"11","author":"Chicharro","year":"2007"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0050","series-title":"Valproate-induced hyperammonaemia","first-page":"631","volume":"22","author":"Raja","year":"2002"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.9740\/mhc.2018.03.073","article-title":"Valproic acid-induced hyperammonemia: incidence, clinical significance, and treatment management","volume":"8","author":"Baddour","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000205512","article-title":"Development of the subjective memory complaints questionnaire","volume":"27","author":"Youn","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0065","first-page":"150","article-title":"\u00d6znel Bellek Yak\u0131nmalar\u0131 Anketi T\u00fcrk\u00e7e Formunun Psikometrik \u00d6zelliklerinin De\u011ferlendirilmesi","volume":"16","author":"\u00d6zel-Kizil","year":"2013","journal-title":"Turk Geriatri Derg"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0075","series-title":"Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population","first-page":"273","volume":"13","author":"G\u00fcngen","year":"2002"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0080","series-title":"Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012","first-page":"562","volume":"54","author":"Cheng","year":"2013"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0085","series-title":"4217C> a polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy","first-page":"1046","volume":"108","author":"Inoue","year":"2014"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0095","series-title":"Carnitine and\/or acetylcarnitine deficiency as a cause of higher levels of ammonia","volume":"2016","author":"Maldonado","year":"2016"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0100","series-title":"Valproic acid-induced encephalopathy in very long course treated patients","first-page":"981","volume":"23","author":"Rousseau","year":"2009"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0105","series-title":"Valproate-induced hyperammonemic encephalopathy with normal liver function","first-page":"226","volume":"53","author":"Rath","year":"2005"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0110","series-title":"Effect of associated antiepileptic treatment on valproate-induced hyperammonemia","first-page":"185","volume":"7","author":"Zaccara","year":"1985"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0115","series-title":"Hepatic encephalopathy\u2014definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","first-page":"716","volume":"35","author":"Ferenci","year":"2002"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0120","series-title":"Minimal hepatic encephalopathy","first-page":"5","volume":"28","author":"Dhiman","year":"2009"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0125","series-title":"Plasma ammonia levels in patients treated with valproic acid","first-page":"42","volume":"7","author":"Tesen","year":"2017"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0130","series-title":"Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting","first-page":"330","volume":"22","author":"M-JCJIcp","year":"2007"},{"key":"10.1016\/j.genhosppsych.2019.05.005_bb0135","series-title":"Discrepancy between subjective memory complaints and objective memory deficits in elderly patients with depression compared to mild cognitive impairment","first-page":"27","author":"Duman","year":"2016"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834319301628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834319301628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T03:59:11Z","timestamp":1562385551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834319301628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":26,"alternative-id":["S0163834319301628"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.05.005","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}